Rights and permissions
About this article
Cite this article
Neoadjuvant hormonal therapy is associated with a low risk of prostate specific antigen (PSA) recurrence in prostate cancer,. Inpharma Wkly. 1256, 17 (2000). https://doi.org/10.2165/00128413-200012560-00042
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200012560-00042